A carregar...

The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs

BACKGROUND: Treatment with disease-modifying anti-rheumatic drugs (DMARDs) has raised concerns about the risk of malignancies in rheumatoid arthritis (RA) patients. However, the association between biologic DMARDs (bDMARDs) and malignancy in previous reports remains controversial. Therefore we aimed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Cho, Soo-Kyung, Lee, Jiyoung, Han, Minkyung, Bae, Sang-Cheol, Sung, Yoon-Kyoung
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5732524/
https://ncbi.nlm.nih.gov/pubmed/29246243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1482-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!